61665-15-4
Chemical Structure
(R)-Moxestrol
Synonym(s): (R)-R 2858; RU 16117
- CAS No.: 61665-15-4
- Formula:C21H26O3
- Molecular Weight:326.43
InChIKey: MTMZZIPTQITGCY-QHOCJJNXSA-N
SMILES: CO[C@H]1[C@@]2([H])[C@](CCC3=CC(O)=CC=C32)([H])[C@@]4([H])[C@](C1)([C@@](O)(CC4)C#C)C
Biological Activity: (R)-Moxestrol ((R)-R 2858; RU 16117) is an orally active weak partial agonist-antagonist of estrogen receptor (ER). (R)-Moxestrol binds to estrogen receptor to form a rapidly dissociating complex, reduces the levels of estrogen and prolactin receptor, exerts weak estrogenic effects at low doses, and displays anti-estrogenic effects at high doses or when competing with Estradiol (E2) (HY-B0141). (R)-Moxestrol can be used in research related to breast cancer and postmenopausal estrogen deficiency (menopausal symptoms, severe osteoporosis)[3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
(R)-Moxestrol | (R)-Moxestrol ((R)-R 2858; RU 16117) is an orally active weak partial agonist-antagonist of estrogen receptor (ER). (R)-Moxestrol binds to estrogen receptor to form a rapidly dissociating complex, reduces the levels of estrogen and prolactin receptor, exerts weak estrogenic effects at low doses, and displays anti-estrogenic effects at high doses or when competing with Estradiol (E2) (HY-B0141). (R)-Moxestrol can be used in research related to breast cancer and postmenopausal estrogen deficiency (menopausal symptoms, severe osteoporosis). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
